Agilon Health Inc. (AGL) Misses Q2 EPS by 3c

Agilon Health Inc. (NYSE: AGL) reported Q2 EPS of ($0.05), $0.03 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $670 million versus the consensus estimate of $648.13 million.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.

You May Also Be Interested In

• Goldman Regional Director in US Adjusts List of Top Names
• FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
• Dynatrace adds two directors after Starboard engagement